Initial Investigation into the Therapeutic Effects and Pharmacological Mechanisms of Modified Danggui-Shaoyao San for Managing Depression in Chronic Kidney Disease Patients
Pharmaceutical Sciences and Drug Design · 2025
DOI: 10.51847/24jvicile0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2025. Verfasst von Isabel Romero und 1 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Depression is a common complication in Chronic Kidney Disease (CKD) that significantly impacts patient prognosis. Modified Danggui-Shaoyao-San (MDSS), an optimized version of the traditional Chinese formula Danggui-Shaoyao-San (DSS), has been developed for depression management. This study aimed to assess the clinical efficacy and safety of MDSS in treating depression in CKD patients and to explore its underlying molecular mechanisms using pharmacological analysis and molecular docking. A total
Zitieren
APA
Romero, I., & Campos, M. (2025). Initial Investigation into the Therapeutic Effects and Pharmacological Mechanisms of Modified Danggui-Shaoyao San for Managing Depression in Chronic Kidney Disease Patients. Pharmaceutical Sciences and Drug Design. https://doi.org/10.51847/24jvicile0
Vancouver
Romero I, Campos M. Initial Investigation into the Therapeutic Effects and Pharmacological Mechanisms of Modified Danggui-Shaoyao San for Managing Depression in Chronic Kidney Disease Patients. Pharmaceutical Sciences and Drug Design. 2025. doi:10.51847/24jvicile0
BibTeX
@article{Romero2025,
author = {Romero, Isabel and Campos, Marta},
title = {Initial Investigation into the Therapeutic Effects and Pharmacological Mechanisms of Modified Danggui-Shaoyao San for Managing Depression in Chronic Kidney Disease Patients},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2025},
doi = {10.51847/24jvicile0}
}
EUVIMED